Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (18,634,000)	$ (20,251,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	94,000	119,000
Stock-based compensation	341,000	474,000
Change in fair value of warrant liability	(1,291,000)	(2,106,000)
Change in fair value of derivative asset	95,000
Loss on settlement of warrants	1,106,000
Loss on warrant issuance		67,000
Changes in operating assets and liabilities:
Accounts receivable	123,000	(786,000)
Prepaid expenses and other current assets	267,000	59,000
Accounts payable	1,914,000	521,000
Accrued expenses	(138,000)	461,000
Deferred revenue	(63,000)	63,000
Net cash used in operating activities	(16,186,000)	(21,379,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(22,000)	(67,000)
Net cash used in investing activities	(22,000)	(67,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, pre-funded warrants, and private placement warrants	7,125,000
Proceeds from issuance of common stock, and pre-funded warrants		4,971,000
Proceeds from exercise of warrants	5,921,000
Proceeds from issuance of preferred stock and warrants	1,697,000
Proceeds from issuance of liability classified warrants in private placement offerings	1,113,000	4,391,000
Proceeds from private offering of common stock		7,302,000
Payments of long-term debt	(76,000)	(74,000)
Net cash provided by financing activities	15,780,000	16,590,000
NET DECREASE IN CASH AND CASH EQUIVALENTS	(428,000)	(4,856,000)
CASH AND CASH EQUIVALENTS–Beginning of period	1,535,000	6,391,000
CASH AND CASH EQUIVALENTS–End of period	$ 1,107,000	$ 1,535,000